Skip to main content

The first Total Artificial Heart (TAH) that truly mimics the human heart and has the potential to revolutionise the market

Objective

The Realheart TAH system (RTS) is the first total artificial heart designed to mimic the structure and function of the human heart. Its unique patented construction of two atria and two ventricles is separated by an atrioventricular plane which contains the valves, enabling to pump blood naturally whilst reducing the risk of blood flow complications. RTS is designed to be efficient (12h battery), silent, lightweight (2.5kg) easy to implant and automatically adapt to different (physiological) activity levels. It consists of two identical artificial heart pumps, a drive line and an intelligent control unit. RTS is connected via a cable through the skin to a controller carried together with two batteries in a belt around the waist. RTS is aimed as a permanent solution for end-stage heart failure patients, but also for patients waiting for a transplant. Realheart will complete GLP animal trial, clinical trial preparatory activities and first-in-man (EFS) trial during the EIC project.

Coordinator

SCANDINAVIAN REAL HEART AB
Net EU contribution
€ 2 500 000,00
Address
Kopparbergsvagen 10
722 13 Vasteras
Sweden

See on map

Region
Östra Sverige Östra Mellansverige Västmanlands län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 35 741 965,75